Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep-Oct;19(5):265-273.
doi: 10.7224/1537-2073.2016-067.

Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting

Meheroz H Rabadi, Christopher E Aston

Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting

Meheroz H Rabadi et al. Int J MS Care. 2017 Sep-Oct.

Abstract

Background: Examining factors that increase risk of death in veterans with multiple sclerosis (MS) may help reduce MS-related mortality. We sought to determine predictors of mortality in veterans with MS attending an outpatient clinic.

Methods: Review of electronic medical records of 226 veterans with MS regularly followed up from January 1, 2000, through December 31, 2014.

Results: Mortality at the end of the 15-year study period was 14%. Patients with MS died prematurely, with a standardized mortality rate of 1.35 relative to the general (Oklahoma) population. The main causes of death documented were MS disease itself (57% of cases), infection (43%), and cancer and respiratory failure (18% each). Cox regression analysis using the whole cohort showed that progressive MS type; older age at entry into the study; presence of sensory, cerebellar, or motor (weakness and/or ataxia) concerns on presentation; more disability on presentation; higher body-mass index; being diabetic; never received disease-modifying therapy; and presence of pressure ulcers or neurogenic bladder were significant predictors of higher mortality.

Conclusions: Initial presentation by MS type (progressive MS), higher level of disability, and associated motor, sensory, and cerebellar concerns are significant predictors of MS-related mortality. The main causes of death were MS disease itself, infection, respiratory disease, and cancer. More attention should be given to preventive strategies that delay mortality, such as yearly immunization and aggressively treating MS-related complications and diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Kaplan-Meier survival curves for relapsing-remitting multiple sclerosis (MS) and primary and secondary progressive MS (A); with and without motor symptoms (B); and ever and never taking disease-modifying therapy (DMT) medication (C) Differences are significant (Mantel-Cox log-rank test) at P < .0001 (A), P = .013 (B), and P = .019 (C).
See this image and copyright information in PMC

References

    1. Noonan CW, Kathman SJ, White MC.. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 2002; 58: 136– 138. - PubMed
    1. Redelings MD, McCoy L, Sorvillo F.. Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology. 2006; 26: 102– 107. - PubMed
    1. McLeod JG, Barnett MH, Macaskill P, Williams DB.. Long-term prognosis of multiple sclerosis in Australia. J Neurol Sci. 2007; 256: 35– 38. - PubMed
    1. Goldacre MJ, Duncan M, Griffith M, Turner MR.. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979–2006. J Neurol. 2010; 257: 706– 715. - PubMed
    1. Smestad C, Sandvik L, Celius EG.. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler. 2009; 15: 1263– 1270. - PubMed

LinkOut - more resources